A controlled trial published in Human Physiology (Dolotov et al., 2006) showed that intranasal Semax at 200 mcg twice daily increased BDNF expression in the basal forebrain by approximately 70% over a seven-day period in patients with ischemic stroke
Both have distinct and complementary roles in glutathione research
Brain and Behavior , 10 (8)
Data represented as mean s.e.m
Preclinical (BDNF/TrkB) Dolotov 2006 demonstrated single-administration BDNF and TrkB increases in rat hippocampus the most-cited mechanistic anchor for the nootropic narrative
it is not a direct substitute for a balanced diet, clinical dermatological treatments, or a healthy lifestyle, nor is it intended to diagnose, treat, cure, or prevent any chronic health issue